Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-04 Sale | 2024-12-06 5:46 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $7.14 | $285,600 | 15,899,344 (Indirect Direct) | View |
| 2024-11-13 Sale | 2024-11-15 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $7.545 | $301,800 | 16,005,367 (Indirect Direct) | View |
| 2024-11-12 Sale | 2024-11-14 7:19 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.6402 | $87,457 | 7,066,113 (Direct) | View |
| 2024-11-12 Sale | 2024-11-14 7:19 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 30,000 | $7.6502 | $229,505 | 3,773,288 (Direct) | View |
| 2024-10-29 Sale | 2024-10-31 6:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.7202 | $76,926 | 7,077,560 (Direct) | View |
| 2024-10-24 Sale | 2024-10-28 5:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $6.3091 | $37,855 | 2,169,187 (Direct) | View |
| 2024-10-15 Sale | 2024-10-17 5:27 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.6678 | $76,326 | 7,089,007 (Direct) | View |
| 2024-10-08 Sale | 2024-10-10 6:40 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 30,000 | $6.3377 | $190,131 | 3,882,038 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 6:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $6.12 | $244,800 | 16,085,367 (Indirect Direct) | View |
| 2024-10-01 Sale | 2024-10-03 4:58 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.2156 | $71,150 | 7,098,428 (Direct) | View |
| 2024-09-26 Sale | 2024-09-30 6:15 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $7.0008 | $42,005 | 2,175,187 (Direct) | View |
| 2024-09-17 Sale | 2024-09-19 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.8431 | $78,333 | 7,109,875 (Direct) | View |
| 2024-09-10 Sale | 2024-09-12 6:28 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 30,000 | $6.2409 | $187,229 | 3,990,788 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 4:57 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $6.09 | $243,600 | 16,165,367 (Indirect Direct) | View |
| 2024-09-03 Sale | 2024-09-05 5:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.2652 | $71,718 | 7,121,322 (Direct) | View |
| 2024-08-29 Sale | 2024-09-03 4:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $7.5627 | $45,376 | 2,181,187 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 6:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.1226 | $81,532 | 7,132,769 (Direct) | View |
| 2024-08-13 Sale | 2024-08-15 5:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 30,000 | $6.3478 | $190,434 | 4,111,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-19 Option Award | 2024-12-20 4:16 pm | N/A 2034-12-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 1,111,029 | $0 | 2,048,635 (Direct) | View |
| 2024-12-16 Tax Withholding | 2024-12-18 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 15,668 | $6.04 | 473,867 (Direct) | View |
| 2024-12-17 Tax Withholding | 2024-12-18 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $6.95 | 473,867 (Direct) | View |
| 2024-12-04 Conversion | 2024-12-06 5:46 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 15,899,344 (Direct) | View |
Ownership | 2024-12-02 7:02 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 0 | $0 | 960,331 (Direct) | View |
| 2024-11-20 Option Award | 2024-11-22 6:25 pm | N/A 2033-05-02 | RECURSION PHARMACEUTICALS INC. | RXRX | Michor Franziska Director | 233,774 | $0 | 251,468 (Direct) | View |
| 2024-11-15 Tax Withholding | 2024-11-19 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer | 4,187 | $6.175 | 706,392 (Direct) | View |
| 2024-11-15 Tax Withholding | 2024-11-19 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 11,937 | $6.175 | 3,384,341 (Direct) | View |
| 2024-11-15 Tax Withholding | 2024-11-19 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 14,286 | $6.175 | 2,154,901 (Direct) | View |
| 2024-11-15 Tax Withholding | 2024-11-19 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 26,023 | $6.175 | 9,902,644 (Direct) | View |
| 2024-11-13 Conversion | 2024-11-15 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,005,367 (Direct) | View |
| 2024-11-12 Exercise | 2024-11-14 7:19 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $0 | 3,773,288 (Direct) | View |
| 2024-11-12 Exercise | 2024-11-14 7:19 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $2.22 | 3,773,288 (Direct) | View |
| 2024-10-24 Exercise | 2024-10-28 5:25 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $1.06 | 2,169,187 (Direct) | View |
| 2024-10-24 Exercise | 2024-10-28 5:25 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $0 | 2,169,187 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-10 6:40 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $0 | 3,882,038 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-10 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $2.22 | 3,882,038 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-04 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 2,026 | $0 | 7,100,454 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-04 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 2,229 | $0 | 106,225 (Direct) | View |
| 2024-10-02 Conversion | 2024-10-04 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,085,367 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-04 6:29 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,925 | $0 | 3,188,547 (Direct) | View |
| 2024-09-26 Exercise | 2024-09-30 6:15 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $1.06 | 2,175,187 (Direct) | View |
| 2024-09-26 Exercise | 2024-09-30 6:15 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 0 | $0 | 2,175,187 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-12 6:28 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $0 | 3,990,788 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-12 6:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $2.22 | 3,990,788 (Direct) | View |
| 2024-09-04 Conversion | 2024-09-06 4:57 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 16,165,367 (Direct) | View |
| 2024-08-29 Exercise | 2024-09-03 4:48 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $1.06 | 2,181,187 (Direct) | View |
| 2024-08-29 Exercise | 2024-09-03 4:48 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 6,000 | $0 | 2,181,187 (Direct) | View |
| 2024-08-30 Exercise | 2024-08-30 4:26 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-30 Exercise | 2024-08-30 4:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-29 4:22 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-29 4:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-28 4:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-28 4:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 4:10 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 4:10 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 4:42 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 4:42 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-23 5:25 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $0 | 10,048,667 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-23 5:25 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 5,000 | $2.48 | 10,048,667 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 7:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 14,319 | $6.69 | 2,187,187 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 7:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer | 14,146 | $6.69 | 710,579 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 7:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 26,082 | $6.69 | 10,048,667 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 7:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 11,962 | $6.69 | 3,486,278 (Direct) | View |
| 2024-08-13 Exercise | 2024-08-15 5:24 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $0 | 4,111,500 (Direct) | View |
| 2024-08-13 Exercise | 2024-08-15 5:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 78,750 | $2.22 | 4,111,500 (Direct) | View |